HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Wound Tumor Virus

Wound Tumor Virus (WTV) is a type of plant virus that primarily affects a variety of crops, causing significant economic losses in agriculture. This virus belongs to the genus Caulimovirus and is transmitted through wounds in plant tissues. WTV is particularly notorious for its ability to exploit injuries caused by mechanical damage, insect feeding, or other environmental stress factors. Once the virus enters the plant through a wound, it initiates a complex series of molecular interactions that lead to the development of tumors or abnormal growths at the infection site. These tumors often hinder the normal physiological functions of the plant, impacting its overall health and productivity. Additionally, WTV can spread to neighboring plants, further exacerbating the problem and contributing to the rapid dissemination of the virus within agricultural settings. Efforts to control Wound Tumor Virus involve implementing preventive measures such as minimizing mechanical damage during cultivation, employing disease-resistant plant varieties, and adopting good agricultural practices. However, managing WTV remains a challenge due to its ability to exploit common agricultural practices that inadvertently cause wounds in plants. Research continues to explore novel strategies for controlling Wound Tumor Virus, including the development of resistant crop varieties through genetic engineering and the identification of antiviral compounds. Despite ongoing efforts, the economic impact of this plant virus underscores the importance of vigilance in agricultural practices to mitigate the risks associated with Wound Tumor Virus infections.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp